COMMUNIQUÉS West-GlobeNewswire

Renovamen Advisors® Launches to Help Early-Stage Biotechs Translate Breakthroughs into Scalable, Investable Business Models
03/09/2025
Renovamen Advisors ® Launches to Help Early-Stage Biotechs Translate Breakthroughs into Scalable, Investable Business Models Guiding biotech teams from scientific breakthroughs to commercial inflection with investor- [...]
Legendary Scientist and Biotech Veteran Joins CancerVax as Strategic Advisor
03/09/2025
Dr. Gordon Ringold to advise on various strategies related to the development of the Company’s novel cancer treatment platform Lehi, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Lehi, Utah, September 3, 2025 – CancerVax, Inc. , [...]
Fangzhou Secures 2nd National Science Foundation Project Approval, Deepens AI-Driven Healthcare Research
03/09/2025
SHANGHAI, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven Internet healthcare solutions, announced that its technology team will collaborate on a National [...]
WeightWatchers Advances International Growth With Strategic Leadership Appointment
03/09/2025
Alejandro Bethlen to Lead WeightWatchers’ Next Phase of International Growth and Innovation, Building on More Than 50 Years in Global Markets NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: [...]
Valneva annonce de nouvelles données positives d’innocuité et d’immunogénicité de Phase 2 pour le candidat vaccin contre la maladie de Lyme
03/09/2025
Forte réponse immunitaire chez les enfants et les adultes après la troisième vaccination annuelle de rappel Forte réponse anamnestique observée pour les six sérotypes Aucun problème de sécurité observé dans toutes les [...]
Valneva Reports Further Positive Phase 2 Safety and Immunogenicity Results for Lyme Disease Vaccine Candidate
03/09/2025
Strong immune response after third yearly booster dose in children and adults Significant anamnestic antibody response across all six serotypes No safety concerns observed in any age group by independent Data Monitoring [...]
NMD Pharma Expands Senior Leadership Team with the Appointment of Ana de Vera as Chief Medical Officer
03/09/2025
NMD Pharma Expands Senior Leadership Team with the Appointment of Ana de Vera as Chief Medical Officer Seasoned clinical development leader brings deep expertise in neuromuscular disease research, drug development, and [...]
Pharming Group to present at the H.C. Wainwright 27th Annual Global Investment Conference
03/09/2025
Leiden, the Netherlands, September 3, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming management will participate in the H.C. Wainwright 27 th Annual Global [...]
Best Kratom Brand Products For Energy and Pain: Happy Go Leafy Introduces New Kratom Collection in 2025
03/09/2025
Discover premium, lab-tested Kratom products designed to boost energy, relieve pain, and support overall wellness with Happy Go Leafy’s 2025 collection. Glendale, CA, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Happy Go Leafy [...]
Allegro appoints life sciences veteran as Chief Operating Officer to advance osteoarthritis treatment
03/09/2025
Stephan Crokaert, formerly of NeoMedLight, Abbott, Adagio and Boston Scientific, brings more than 35 years of strategic and commercial experience in life sciences Allegro prepares to advance lead product hydrocelin into [...]
Mineralys Therapeutics Announces Pricing of Upsized $250.0 Million Underwritten Public Offering of Common Stock
03/09/2025
RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities [...]
BioSig Technologies Supplements Clarification on Recent Schedule 14A Filing. Closing of Merger with Streamex Exchange Corporation Not Affected
03/09/2025
Proposal No. 1 (The Acquisition Proposal) to be adjourned pending final NASDAQ approval; Company operations, financings and closing of the merger transaction remain not impacted LOS ANGELES and VANCOUVER, British [...]
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status
03/09/2025
LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home injection from the start to help patients and care partners treat this progressive, relentless [...]
Expert on Sham Peer Review Discusses Tactic of Not Allowing Doctor’s Attorney to Speak, in the Journal of American Physicians and Surgeons
02/09/2025
TUCSON, Ariz., Sept. 02, 2025 (GLOBE NEWSWIRE) -- A physician who is a victim of sham peer review at his hospital may be shocked to learn that some medical staff bylaws prohibit the physician’s attorney from speaking at [...]
SYNDEO Medical Announces Multi-Year Exclusive Distribution Agreement for Bearpac’s Passio™ Pump Drainage System
02/09/2025
ZAVENTEM, Belgium, Sept. 02, 2025 (GLOBE NEWSWIRE) -- SYNDEO Medical today announced a multi-year exclusive distribution agreement with Bearpac Medical for the Passio™ Pump Drainage System, granting SYNDEO exclusive [...]
Evidence for ‘Chemtrails’ Examined in the Journal of American Physicians and Surgeons
02/09/2025
TUCSON, Ariz., Sept. 02, 2025 (GLOBE NEWSWIRE) -- The “chemtrails” theory gained prominence in the Make America Healthy Again (MAHA) movement, leading to the enactment of related legislative measures. In the fall issue [...]
The Implications of Artificial Intelligence (AI) for Medicine Discussed in the Journal of American Physicians and Surgeons
02/09/2025
TUCSON, Ariz., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Artificial intelligence (AI) is envisioned by many to be the future of medicine, and it is critical to understand its implications and the background of technocracy, [...]
Harms from Modified mRNA COVID-19 Vaccines Discussed in the Journal of American Physicians and Surgeons
02/09/2025
TUCSON, Ariz., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Experience to date indicates that modified mRNA COVID-19 vaccines can disrupt every body system, and that urgent scrutiny and accountability are needed, write Andrew [...]
Cognition Therapeutics Closes $30 Million Registered Direct Offering to Two New Fundamental Institutional Investors, Including a Preeminent Global Investment Firm to Support Phase 3 Development of Zervimesine (CT1812)
02/09/2025
PURCHASE, N.Y., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, closed [...]

Pages